Read More
💊 Acquisition of Verona Pharma for 10 billion USD!
Pharmaceutical giant Merck $MRK is expanding its portfolio as it announced the acquisition of Verona Pharma $VRNA, a British company specializing in the treatment of chronic lung disease (COPD). The value of the acquisition is expected to reach approximately $10 billion. This is the company's largest transaction since 2023 a...
Read more
The company doesn't have much cash and I don't like the fundamentals either.